Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
NCT01338064 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2011-04-19
Summary
Silicosis is well-known occupational disease caused by free crystalline silica (silicon dioxide) and is marked by inflammation and pulmonary fibrosis. There are cumulative evidences that exposure to Caesar stone (quartz surface products that manufactured from up to 93% quartz, polymer resins and pigments) is particularly dangerous to exposed workers.
Goals: To examine marble workers exposed to Caesar Stone in order to propose a working plan of surveillance and prevention by biological monitoring.
Conditions
- Silicosis
Sponsors & Collaborators
-
Rabin Medical Center
collaborator OTHER -
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Yehuda Shwartz, MD · Tel Aviv medical center. Pulmonary and Allergy department
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Israel
Study Locations
More Related Trials
-
Study of Silicone-Associated Connective Tissue Diseases
NCT00001330 ·Status: COMPLETED
-
Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers
NCT02191813 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
NCT03558854 ·Status: COMPLETED ·Phase: PHASE4
-
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
NCT05156138 ·Status: UNKNOWN
-
Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers
NCT02099136 ·Status: COMPLETED ·Phase: PHASE2
-
NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc
NCT02795221 ·Status: UNKNOWN
-
An Assessment of TLR4 and TOPK/PRPK Signaling in Sun Damaged Human Skin Acutely Exposed to Solar Simulated Light
NCT05398237 ·Status: COMPLETED ·Phase: NA
-
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients
NCT07282717 ·Status: RECRUITING
-
Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
NCT03060551 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers
NCT02090933 ·Status: COMPLETED ·Phase: PHASE2
-
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
NCT07228429 ·Status: RECRUITING
-
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02422407 ·Status: COMPLETED
-
Calcinosis in a Single-Center Scleroderma Population
NCT02062125 ·Status: COMPLETED
-
BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA
NCT03629002 ·Status: UNKNOWN
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414 ·Status: RECRUITING
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
NCT01813279 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
NCT03508375 ·Status: UNKNOWN ·Phase: NA
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
NCT03268330 ·Status: UNKNOWN
-
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
NCT06546540 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness and Safety of Lidocaine for Scleroderma
NCT00740285 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA